Header Logo

Connection

Ravindre Panchia to HIV Integrase Inhibitors

Back to Details
This is a "connection" page, showing publications Ravindre Panchia has written about HIV Integrase Inhibitors.
Ravindre Panchia
Connection Strength
0,172
HIV Integrase Inhibitors
  1. Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial. Lancet HIV. 2020 07; 7(7):e472-e481.
    View in: PubMed
    Score: 0,172
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.